Cargando…

ERCP-related perforations: a population-based study of incidence, mortality, and risk factors

BACKGROUND: Perforations related to endoscopic retrograde cholangiopancreatography (ERCP) are rare but feared adverse events with highly reported morbidity and mortality rates. The aim was to evaluate the incidence and outcome of ERCP-related perforations and to identify risk factors for death due t...

Descripción completa

Detalles Bibliográficos
Autores principales: Langerth, Ann, Isaksson, Bengt, Karlson, Britt-Marie, Urdzik, Jozef, Linder, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113211/
https://www.ncbi.nlm.nih.gov/pubmed/31559577
http://dx.doi.org/10.1007/s00464-019-06966-w
_version_ 1783513622195994624
author Langerth, Ann
Isaksson, Bengt
Karlson, Britt-Marie
Urdzik, Jozef
Linder, Stefan
author_facet Langerth, Ann
Isaksson, Bengt
Karlson, Britt-Marie
Urdzik, Jozef
Linder, Stefan
author_sort Langerth, Ann
collection PubMed
description BACKGROUND: Perforations related to endoscopic retrograde cholangiopancreatography (ERCP) are rare but feared adverse events with highly reported morbidity and mortality rates. The aim was to evaluate the incidence and outcome of ERCP-related perforations and to identify risk factors for death due to perforations in a population-based study. METHODS: Between May 2005 and December 2013, a total of 52,140 ERCPs were registered in GallRiks, a Swedish nationwide, population-based registry. A total of 376 (0.72%) were registered as perforations or extravasation of contrast during ERCP or as perforation in the 30-day follow-up. The patients with perforation were divided into fatal and non-fatal groups and analyzed for mortality risk factors. The case volume of centers and endoscopists were divided into the upper quartile (Q4) and the lower three quartile (Q1–3) groups. Furthermore, fatal group patients’ records were reviewed. RESULTS: Death within 90 days after ERCP-related perforations or at the index hospitalization occurred in 20% (75 out of 376) for all perforations and 0.1% (75 out of 52,140) for all ERCPs. The independent risk factors for death after perforation were malignancy (OR 11.2, 95% CI 5.8–21.6), age over 80 years (OR 3.8, 95% CI 2.0–7.4), and sphincterotomy in the pancreatic duct (OR 2.8, 95% CI 1.1–7.5). In Q4 centers, the mortality was similar with or without pancreatic duct sphincterotomy (14% vs. 13%, p = 1.0), but in Q1–3 centers mortality was higher (45% vs. 21%, p = 0.024). CONCLUSIONS: ERCP-related perforations are severe adverse events with low incidence (0.7%) and high mortality rate up to 20%. Malignancy, age over 80 years, and sphincterotomy in the pancreatic duct increase the risk to die after a perforation. The risk of a fatal outcome in perforations after pancreatic duct sphincterotomy was reduced when occurred at a Q4-center. In the case of a complicated perforation a transfer to a Q4-center may be considered.
format Online
Article
Text
id pubmed-7113211
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-71132112020-04-06 ERCP-related perforations: a population-based study of incidence, mortality, and risk factors Langerth, Ann Isaksson, Bengt Karlson, Britt-Marie Urdzik, Jozef Linder, Stefan Surg Endosc Article BACKGROUND: Perforations related to endoscopic retrograde cholangiopancreatography (ERCP) are rare but feared adverse events with highly reported morbidity and mortality rates. The aim was to evaluate the incidence and outcome of ERCP-related perforations and to identify risk factors for death due to perforations in a population-based study. METHODS: Between May 2005 and December 2013, a total of 52,140 ERCPs were registered in GallRiks, a Swedish nationwide, population-based registry. A total of 376 (0.72%) were registered as perforations or extravasation of contrast during ERCP or as perforation in the 30-day follow-up. The patients with perforation were divided into fatal and non-fatal groups and analyzed for mortality risk factors. The case volume of centers and endoscopists were divided into the upper quartile (Q4) and the lower three quartile (Q1–3) groups. Furthermore, fatal group patients’ records were reviewed. RESULTS: Death within 90 days after ERCP-related perforations or at the index hospitalization occurred in 20% (75 out of 376) for all perforations and 0.1% (75 out of 52,140) for all ERCPs. The independent risk factors for death after perforation were malignancy (OR 11.2, 95% CI 5.8–21.6), age over 80 years (OR 3.8, 95% CI 2.0–7.4), and sphincterotomy in the pancreatic duct (OR 2.8, 95% CI 1.1–7.5). In Q4 centers, the mortality was similar with or without pancreatic duct sphincterotomy (14% vs. 13%, p = 1.0), but in Q1–3 centers mortality was higher (45% vs. 21%, p = 0.024). CONCLUSIONS: ERCP-related perforations are severe adverse events with low incidence (0.7%) and high mortality rate up to 20%. Malignancy, age over 80 years, and sphincterotomy in the pancreatic duct increase the risk to die after a perforation. The risk of a fatal outcome in perforations after pancreatic duct sphincterotomy was reduced when occurred at a Q4-center. In the case of a complicated perforation a transfer to a Q4-center may be considered. Springer US 2019-09-26 2020 /pmc/articles/PMC7113211/ /pubmed/31559577 http://dx.doi.org/10.1007/s00464-019-06966-w Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Langerth, Ann
Isaksson, Bengt
Karlson, Britt-Marie
Urdzik, Jozef
Linder, Stefan
ERCP-related perforations: a population-based study of incidence, mortality, and risk factors
title ERCP-related perforations: a population-based study of incidence, mortality, and risk factors
title_full ERCP-related perforations: a population-based study of incidence, mortality, and risk factors
title_fullStr ERCP-related perforations: a population-based study of incidence, mortality, and risk factors
title_full_unstemmed ERCP-related perforations: a population-based study of incidence, mortality, and risk factors
title_short ERCP-related perforations: a population-based study of incidence, mortality, and risk factors
title_sort ercp-related perforations: a population-based study of incidence, mortality, and risk factors
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113211/
https://www.ncbi.nlm.nih.gov/pubmed/31559577
http://dx.doi.org/10.1007/s00464-019-06966-w
work_keys_str_mv AT langerthann ercprelatedperforationsapopulationbasedstudyofincidencemortalityandriskfactors
AT isakssonbengt ercprelatedperforationsapopulationbasedstudyofincidencemortalityandriskfactors
AT karlsonbrittmarie ercprelatedperforationsapopulationbasedstudyofincidencemortalityandriskfactors
AT urdzikjozef ercprelatedperforationsapopulationbasedstudyofincidencemortalityandriskfactors
AT linderstefan ercprelatedperforationsapopulationbasedstudyofincidencemortalityandriskfactors